$AKER new breakout Pr. $2.54
Nasdaq CM ultra low
$AKER new breakout Pr. $2.54
Nasdaq CM ultra low float
Website
7:01 am Akers Biosciences signs distribution agreement for BreathScan OxiChek with Aero-Med, a division of Cardinal Health (CAH)Briefing.com(Mon 7:01AM EDT)
Akers Biosciences Signs Distribution Agreement for BreathScan OxiChek(TM)Marketwired(Mon 7:00AM EDT)
Shares Outstanding: 5.42M
Float: 3.70M
% Held by Insiders: 19.40%
% Held by Institutions: 8.80%
Shares Short (as of May 31, 2016): 13.80K
Short Ratio (as of May 31, 2016): 0.60
Short % of Float (as of May 31, 2016): 0.30%
Shares Short (prior month): 11.63K
Headlines
Akers Biosciences, Inc., together with its subsidiaries, focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. The companys marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor weight loss; and PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin. Its marketed products also comprise seraSTAT, a blood cell separator; Tri-Cholesterol Check, a test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. The companys pipeline products consists of Breath Ketone Check, a disposable breath ketone device for diabetic monitoring, and management of senile dementia and alzheimers disease patients; Breath PulmoHealth Check, a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia to test sexually transmitted disease; and PIFA PLUSS TroponinI for the diagnosis of a myocardial infarction. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.
TNF Pharmaceuticals Inc. (TNFA) Stock Research Links
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...
Continue Reading
Are We Dropping the Ball on Future Talent? Listen, there’s a harsh truth screaming at us from the NWEA’s latest study, and it’s not pretty. We’re talking about a serious gap here, folks—one that shows lower-income kids are getting the short end of the stick in education yet again. When more than half of U.S. students come from lower-income families but only 20%...
Continue Reading
Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...
Continue Reading
Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...
Continue Reading
Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...
Continue Reading
Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...
Continue Reading
Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...
Continue Reading
Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...
Continue Reading
A Long-Standing Question Finally Answered There comes a time when asking the same question repeatedly feels like chasing your own tail. That's where Bill Marler, food safety attorney extraordinaire, found himself after two decades of wondering if petting zoos should face the chopping block. Right on the heels of E. coli investigations across Illinois, California, and...
Continue Reading
Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to Neuboron Medical Group's Innovations Neuboron Medical Group is at the forefront of revolutionizing cancer treatment through its advanced use of Boron Neutron Capture Therapy (BNCT). This technology has gained momentum worldwide, and Neuboron is making significant strides with the creation of China's first accelerator-based BNCT demonstration center in...
Continue Reading
As the trading session wrapped up in France, it was clear: the stock market painted a pretty chaotic picture. The CAC 40 index took a hit, dropping by 2.00%. Meanwhile, the SBF 120 index managed to climb a bit, up by 0.66%. This kind of mixed performance suggests investors were split—some panicking while others sniffed out opportunities in the mayhem. CAC 40 Drama: Top...
Continue Reading
Man Group’s Position Disclosure Regarding Darktrace Man Group PLC has recently published a notable disclosure concerning its interests in Darktrace plc, which has sparked interest among investors and market analysts. This move complies with Rule 8.3 of the Takeover Code, which requires transparency about positions in relevant securities. Let’s take a closer look at...
Continue Reading
Apollo's Strategic Fund Closure Signals Confidence in Credit Markets In a bold move that reflects confidence in the evolving financial landscape, Apollo recently closed on $8.5 billion in total commitments for its Accord+ strategy. This remarkable achievement includes a significant $4.8 billion earmarked for the Accord+ Fund II, demonstrating not only robust investor...
Continue Reading
Perseus Mining Makes a Strategic Move with Predictive Discovery Perseus Mining Limited (ASX/TSX: PRU) has announced an exciting proposal to acquire Predictive Discovery Limited (ASX: PDI), a bold step that highlights its commitment to growth in the mining sector. This proposed acquisition involves a definitive binding offer for all issued shares in Predictive Discovery...
Continue Reading